Latest Commercialization News

Singular Health has secured a pivotal MoU with Miami-based Provider Network Solutions and raised $3.7 million to propel its 3Dicom software towards a US commercial pilot, supported by the appointment of esteemed radiologist Dr. Ronny Low.

Enova Mining Limited has completed a $1.5 million placement to fund key developments at its CODA and Charley Creek projects, with the second tranche awaiting shareholder approval.

Enova Mining has completed a $1.5 million placement to fund key development and exploration activities across its CODA, Charley Creek, and Lithium Valley projects. The capital injection aims to accelerate metallurgical testing and engineering work critical to unlocking the value of these rare earth and critical mineral assets.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Enova Mining has secured $1.5 million through a two-tranche placement to fund key project developments and exploration activities across its lithium and rare earth assets in Brazil and Australia.

Anatara Lifesciences has been granted a key Australian patent for its GaRP gastrointestinal health product, reinforcing its intellectual property portfolio ahead of pivotal clinical trial results expected in March 2025.

AnteoTech has marked a pivotal quarter with its first commercial Ultranode™ order shipped to Mercedes-Benz and a $4.3 million capital raise to accelerate growth in clean energy and life sciences.

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.

Eastern Resources Limited's December 2024 quarterly cash flow report reveals a modest operating cash outflow amid ongoing exploration expenses, supported by a healthy cash reserve expected to sustain operations for over 19 quarters.

Eastern Resources Limited reports solid progress in its lithium and iron projects during the December 2024 quarter, highlighted by promising metallurgical test results from Lepidolite Hill.

Zeotech Limited has secured a strategic MOU with Holcim Australia to advance its AusPozz™ low-carbon concrete product, alongside promising methane reduction results and a newly granted Japanese patent.